Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 24.3B | 30.5B | 24.7B | 22.7B |
Cost of revenue | 15.4B | 20.2B | 16.0B | 14.3B |
Gross profit | 8.9B | 10.4B | 8.6B | 8.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.3B | 2.4B | 2.2B | 2.2B |
Operating income | 4.8B | 5.5B | 4.4B | 4.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 52.9M | 30.2M | 25.8M | 49.6M |
Other income expense | — | — | — | — |
Pretax income | 6.9B | 7.1B | 5.9B | 6.0B |
Tax provision | 1.6B | 1.6B | 1.4B | 1.3B |
Net income | 5.3B | 5.6B | 4.5B | 4.6B |
Basic EPS | — | 20.2 | 16.2 | 16.7 |
Diluted EPS | — | 20.2 | 16.2 | 16.7 |
Basic average shares | — | 277.2M | 277.2M | 277.2M |
Diluted average shares | — | 277.2M | 277.2M | 277.2M |
EBITDA | 7.4B | 7.7B | 6.4B | 6.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |